Answer
Cholestyramine may lessen the additional LDL-cholesterol reduction from adding INEGY because concomitant administration decreases total ezetimibe exposure (mean AUC) by approximately 55%.
Sources for this answer
- INEGY TabletsOrganon Pharma (UK) Limited · emc · SmPC §4.5 Interaction with other medicinal products · Version 38Document updated
Sources checked